Recent

% | $
Quotes you view appear here for quick access.

Illumina Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • patworth123 patworth123 May 15, 2012 3:11 PM Flag

    The buyback has begun. This should

    Roche has already announced a new alliance with SoftGenetics, but none of their behavior at this time is a reflection of the value of ILMN's value and science long term. Ilumina is still the gold standard and whether Roche returns or turns its attention to a patchwork of others should not be an investor's measure to determine whether to buy, sell, or hold. Global growth and the demand for more and more sophisticated analysis in the healthcare sciences community will continue to support ILMN's growth or its value for an acquisition by a large pharma or tech company. Roche is just one of many with similar reasons to own this technology. It certinly isn't the only one with the need or the capacity.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ILMN
143.12-0.43(-0.30%)May 26 4:00 PMEDT